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0 [-5, 5] vs. no LBBB: 0 [0, 10], p¼0.003).
CONCLUSIONS New LBBB is not uncommon after TAVR with higher
incidence observed in patients receiving self-expanding Medtronic
CoreValve system. Although a small proportion of patients progressed
to CHB, the majority did not require PPM implantation. New LBBB was
associated with worse left ventricular EF on 30-day follow-up.
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BACKGROUND As transcatheter aortic valve replacement (TAVR) is
being considered for surgical patients of lower risk and younger age,
concerns remain regarding TAVR durability. From a valve design
perspective, durability decreases with increased stresses on the stent
and leaﬂets. Patient annulus sizes can fall within the grey zone be-
tween two TAVR sizes, but the impact of valve size on TAVR stresses
is unknown. The goal of this study was to determine and compare
stent and leaﬂet stresses of 2 TAVR sizes using exact fully expanded
geometry.
METHODS Edwards Sapien XT 26mm and 29mm (Edwards Life-
sciences, Inc) underwent micro-computed tomography scanning.
Radiologic images were used to create precise models including stent,
leaﬂets, Dacron, and suture connections. Finite element meshes were
generated and simulations were performed using ABAQUS software to
load both TAVR sizes to 80mmHg then 120mmHg. Analyses of 26 and
29mm Sapien XT were compared to determine differences in stent and
leaﬂet stresses at 120mmHg.
RESULTS For TAVR stents, peak ﬁrst principal stresses on 26mm and
29mm Sapien XT were 68.1MPa and 62.0MPa, respectively (Figure 1);
while peak second principal stresses were -67.7MPa and -61.2MPa,
respectively. For TAVR leaﬂets, peak ﬁrst principal stresses were
5.9MPa and 5.1MPa for 26mm and 29mm Sapien XT, respectively;
while peak second principal stresses were -5.05MPa and -3.8MPa,
respectively.CONCLUSIONS Finite element analyses demonstrated that for both
stents and leaﬂets, stresses were greater in the 26mm compared to
29mm Edwards Sapien XT. Our results suggest the smaller TAVR size
had increased stresses which may impact durability. Comparison with
similarly sized surgical bioprostheses may lead to further insight into
relative TAVR durability.
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BACKGROUND Evaluation for transcatheter aortic valve replacement
(TAVR) has brought a renewed interest in the role for balloon aortic
valvuloplasty (BAV) in the management of patients with severe aortic
stenosis (AS). The current study is the ﬁrst prospective study of BAV
analyzed by intent-to-treat.
METHODS This is a prospective, two center study of 100 high-risk
patients undergoing BAV for management of severe AS. Before the
procedure, physicians assigned intent of BAV as 1) bridge to decision
for treatment (BTD); 2) therapeutic bridge to planned therapy (BTX);
or 3) palliation (PAL). Patients in the BTD arm underwent clinical
assessment at 30 days in the valve clinic to determine eligibility for
deﬁnitive valve therapy. Baseline demographics were recorded as per
the Society of Thoracic Surgeons (STS) deﬁnitions. All patients were
followed to 1 year, with outcomes measured including procedural
complications, 30-day and 1-year mortality, and deﬁnitive valve
therapy.
RESULTS At baseline, the patients had a mean (standard deviation)
age of 80.6 (9.6) years, STS predicted risk of mortality of
11.4%(7.1%), and there were 91 (91.0%) patients with a Class III or IV
New York Heart Association Congestive Heart Failure. Intent and
treatment outcomes in the 100 patients enrolled are shown in the
ﬁgure: 73 BTD; 23 BTX; and 4 PAL. 30-day mortality for all patients
was 6/100 (6.0%). One of these patients was in the palliative cohort
and 5 were in the BTD cohort and were not referred for deﬁnitive
valve replacement. Other complications included cerebrovascular
accident in 2/100 (2.0%) and acute renal injury in 4/100 (4.0%). 1-year
mortality for patients who received deﬁnitive valve therapy was 6/54
(11.1%), with no valve was 32/42 (76.2%), and 3/4 (75.0%) for pallia-
tion. Of the patients in the BTD arm referred for deﬁnitive valve
